Discussing the Regulatory Perspective for Comparability in Gene Therapy Analytical Development

Time: 8:30 am
day: Conference Day Two


  • Addressing the additional challenges in comparability specific to gene therapies
  • Ensuring comparability and dosing strategies keep up with changing instrumentation and non-direct comparable results
  • How do assays needed for comparability studies alter as gene therapies enter later phase development?